Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospitals Cleveland Medical Center
With
Case Western Reserve University
National Center for Complementary and Integrative Health (NCCIH)
This study will focus on subjects with documented zinc deficiency (levels \<75 µg/dl) as group most likely to benefit from the zinc supplementation. The investigators also acknowledge that zinc may be beneficial in all HIV subjects, regardless of the plasma zinc level; however initial studies should be done in subjects with low zinc levels as they are more likely to benefit.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
HIV-1 infection
Documentation of an HIV-1 RNA level of ≤400 copies/mL in the last 4 months prior to study entry
Male or Female age ≥18 years
Zinc level ≤0.75 mg/L in the last 60 days
You may not be if
Pregnancy/lactation
Known cardiovascular disease
Uncontrolled diabetes
Clareo Health | Zinc Effect on Inflammation and Cardiovascular Risk in HIV
